Comparison of Early Clinical Results of Transcatheter versus Surgical Aortic Valve Replacement in Symptomatic High Risk Severe Aortic Stenosis Patients
´ëÇÑÈäºÎ¿Ü°úÇÐȸÁö 2013³â 46±Ç 5È£ p.346 ~ p.352
À¯¿ì½Ä(Yu Woo-Sik) - Yonsei University College of Medicine Department of Thoracic and Cardiovascular Surgery
À庴ö(Chang Byung-Chul) - Yonsei University College of Medicine Department of Thoracic and Cardiovascular Surgery
ÁÖÇöö(Joo Hyun-Chel) - Yonsei University College of Medicine Department of Thoracic and Cardiovascular Surgery
°í¿µ±¹(Ko Young-Guk) - Yonsei University College of Medicine Department of Cardiology
ÀÌ»è(Lee Sak) - Yonsei University College of Medicine Department of Thoracic and Cardiovascular Surgery
Abstract
Background: Transcatheter aortic valve implantation (TAVI) has been an alternative to conventional aortic valve re-placement (AVR) in old and high risk patients. The goal of this study is to compare the early outcomes of con-ventional AVR vs. TAVI in high risk severe AS patients.
Methods: From January 2008 to July 2012, 44 high risk severe aortic stenosis patients underwent conventional AVR, and 15 patients underwent TAVI. We compared echo-cardiographic data, periprocedural complication, and survival. The mean follow-up duration was 14.5¡¾10 months (AVR), and 6.8¡¾3.5 months (TAVI), respectively.
Results: AVR group was younger (78.2¡¾2.4 years vs. 82.2¡¾3.0 years, p£¼0.001) and had lower operative risk (Euroscore: 9.4¡¾2.7 vs. 11.0¡¾2.0, p=0.044) than TAVI group. There was no significant difference in early mortality (11.4% vs. 13.3%, p=0.839), and 1 year survival (87.4%¡¾5.3% vs. 83.1%¡¾1.1%, p=0.805). There was no significant difference in postoperative functional class. There was no sig-nificant difference in periprocedural complication except vascular complication (0% [AVR] vs. 13.3% [TAVI], p=0.014). TAVI group had more moderate and severe paravalvular leakage.
Conclusion: In this study, both groups had sim-ilar periprocedural morbidity, and mortality. However, TAVI group had more greater than moderate paravalvular leak-age, which can influence long-term outcome. Since more patients are treated with TAVI even in moderate risk, careful selection of the patients and appropriate guideline need to be established.
Ű¿öµå
Aortic valve stenosis, Aortic valve, surgery, Transcatheter aortic valve implantation
KMID :
0364020130460050346
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
In this study, the TAVI group had a similar 1-year survival to the AVR group despite the fact that TAVI was performed in older and higher risk patients; AVR group was younger (78.2¡¾2.4 years vs. 82.2¡¾3.0 years, p£¼0.001) and had lower operative risk (Euroscore: 9.4¡¾2.7 vs. 11.0¡¾2.0, p=0.044) than TAVI group. There was no significant difference in early mortality (11.4% vs. 13.3%, p=0.839), and 1 year survival (87.4%¡¾5.3% vs. 83.1%¡¾1.1%, p=0.805).